Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome (2012)
- Autores:
- Autores USP: MACEDO, CAROLINA SALES VIEIRA - FMRP ; FERRIANI, RUI ALBERTO - FMRP
- Unidade: FMRP
- DOI: 10.1002/uog.10084
- Assuntos: SÍNDROME DO OVÁRIO POLICÍSTICO; OBESIDADE; DOENÇAS CARDIOVASCULARES; DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS
- Idioma: Inglês
- Imprenta:
- Local: Chichester
- Data de publicação: 2012
- Fonte:
- Título do periódico: Ultrasound in obstetrics and Gynecology
- ISSN: 1469-0705
- Volume/Número/Paginação/Ano: v. 40, n. 3, p. 341-347, 2012
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
ZUEFF, L. F. N. et al. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome. Ultrasound in obstetrics and Gynecology, v. 40, n. 3, p. 341-347, 2012Tradução . . Disponível em: https://doi.org/10.1002/uog.10084. Acesso em: 23 abr. 2024. -
APA
Zueff, L. F. N., Martins, W. P., Vieira, C. S., & Ferriani, R. A. (2012). Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome. Ultrasound in obstetrics and Gynecology, 40( 3), 341-347. doi:10.1002/uog.10084 -
NLM
Zueff LFN, Martins WP, Vieira CS, Ferriani RA. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome [Internet]. Ultrasound in obstetrics and Gynecology. 2012 ; 40( 3): 341-347.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1002/uog.10084 -
Vancouver
Zueff LFN, Martins WP, Vieira CS, Ferriani RA. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome [Internet]. Ultrasound in obstetrics and Gynecology. 2012 ; 40( 3): 341-347.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1002/uog.10084 - Contracepção na adolescência
- Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis
- Effects of two contraceptives containing drospirenone on blood pressure in normotensive women: a randomized-controlled trial
- Effect of the levonorgestrel releasing intrauterine system on cardiovascular risk markers among women with thrombophilia or previous venous thromboembolism
- Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel-releasing intrauterine system insertion in women without previous vaginal delivery
- Satisfaction score and metabolic effects of the use of levonorgestrel-releasing intrauterine system in nonobese women with polycystic ovary syndrome
- Timing of etonogestrel-releasing implants and growth of breastfed infants: a randomized controlled trial
- Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome
- Body composition characteristics predict sexual functioning in obese women with or without PCOS
- Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial
Informações sobre o DOI: 10.1002/uog.10084 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
